Objective: We have previously demonstrated that myocardium is capable of down-regulating its 0, requirements and thus avoiding ischaemia when 0, supply is limited. The present study tested the hypothesis that endogenous adenosine produced this protective response when 0, supply was decreased by moderate coronary hypoperfusion or moderate coronary hypoxaemia. Methods: In anaesthetised dogs, hearts were exposed by left thoracotomy and instrumented for measuring intraventricular pressure and regional myocardial segment length. The left anterior descending coronary artery was isolated, cannulated, and extracorporeally perfused. Coronary 0, supply was moderately reduced by lowering coronary perfusion pressure from 100 to 60 mmHg or by lowering coronary arterial 0, content by 50%. Hearts were treated with intracoronary infusions of adenosine, adenosine deaminase to degrade endogenous adenosine or with erythro-9-(Z-hydroxy-3-nonyl)-adenine .
Introduction
The working myocardium contains limited endogenous energy reserves and consequently is highly dependent on substrates and oxygen supplied by the coronary circulation. When myocardial 0, demand exceeds coronary 0, supply, ischaemia typically ensues. 0, supply/demand imbalance can result from decreased 0, supply, e.g. due to coronary stenosis or hypoxaemia, or from increased 0, demand, e.g. due to inotropic stimulation.
However, recent findings from this laboratory [I] suggest that isoprenalineTime for primary review 34 days. stimulated myocardium may have the ability to decrease its 0, demand and avoid ischaemia when coronary 0, supply is moderately lowered. Thus, during moderate reductions in coronary perfusion pressure, function as reflected by contractile power was maintained and 0, utilisation efficiency was increased, whereas during moderate coronary hypoxaemia, global and regional power was lowered. In both cases, 0, consumption fell, and myocardial ischaemia was not evident. The mechanisms for this protective down-regulation of 0, demand have not been delineated and may differ between hypoperfusion and hypoxaemia.
Increased myocardial energy demand or decreased coronary supply of 0, and substrate promotes adenosine production and release secondary to myocardial de-energization [2-51. Adenosine, in turn, could improve myocardial 0, supply/demand ratio by either increasing 0, supply or decreasing 0, demand. 0, supply might be increased by the well-characterised coronary vasodilatory response to adenosine [6] . However, adenosine could also act to lessen myocardial 0, demand, and such an action could be particularly beneficial under conditions where vasodilation cannot improve 0, supply. Adenosine is known to antagonise the inotropic effects of catecholamines [7-91 and could serve to limit myocardial energy demand during adrenergic stimulation. Other metabolic mechanisms may also be involved. Recently, endogenous adenosine has been found to optimise myocardial efficiency in an isolated, nonworking perfused heart model [lo] .
This study tested the hypothesis that adenosine mediates down-regulation of myocardial 0, demand when myocardial workload is increased by adrenergic stimulation and 0, supply is simultaneously limited. The role of adenosine was evaluated during coronary hypoperfusion and hypoxaemia, to test the hypothesis that adenosine mediates down-regulation in response to both of these stresses, in which the myocardial responses producing down-regulation are different [l] . In an in situ canine heart preparation, myocardium was subjected to regional hypoperfusion or hypoxaemia in combination with P-adrenergic stimulation with isoprenaline. During these treatments, adenosine deaminase was administered to degrade endogenous adenosine, or erythro-9-(2-hydroxy-3-nonyl)-adenine . HCl was infused to inhibit endogenous adenosine deaminase [ 1 I] and thus augment myocardial interstitial adenosine concentrations. Myocardial 0, utilisation efficiency was assessed from regional myocardial power and 0, consumption [ 11.
2. Methods 2.1. Heart preparation All surgical and experimental procedures were approved by the animal care and use committee of the University of North Texas Health Science Center and were in accordance with the Guide to the Care and Use of Laboratory Animals (NIH publication 85-23, revised 198.5). 33 mongrel canines (15-35 kg), free of clinically evident disease, were enrolled in the study. Dogs were fasted for 24 h prior to surgery. Surgical procedures have been described in detail previously [l] and are summarised as follows. Dogs were anaesthetised with thiamylal sodium (20 mg . kg-' i.v.> and a-chloralose (80 mg . kg-' i.v., plus supplements), intubated, and mechanically ventilated with room air supplemented with 0,. Vinyl catheters were placed in the left carotid artery to measure systemic arterial pressure, in the left femoral vein to administer supplementary cr-chloralose, fluids, and donor blood, and in the left femoral artery to withdraw blood for the extracorporeal coronary perfusion circuit (see below). Hearts were exposed through the left fifth intercostal space and suspended in a pericardial cradle. Left intraventricular pressure was monitored with a high-fidelity micromanometer (Millar Instruments, Houston, TX) inserted into the left atria1 appendage and advanced across the mitral valve. Left ventricular d P/d t was obtained by electronic differentiation of the left intraventricular pressure signal.
Assessment of regional myocardial function
Segmental function in the perfusion territory of the left anterior descending coronary artery was monitored by sonomicrometry. Piezoelectric crystals, implanted in pairs l-l.5 cm apart in the mid-myocardium, were oriented perpendicular to the heart's major axis, i.e. parallel to the fibre orientation in the mid-myocardium [ 121. End-diastole and end-systole were defined as the beginning of the positive upstroke of the d P/d t signal and 20 ms prior to the nadir of negative d P/dt, respectively. Percent systolic segment shortening was calculated as 100 . (end-diastolic length -end-systolic length)/end-diastolic length. Regional myocardial power was indexed as the product of percent systolic segment shortening, heart rate (min-' >, and left ventricular developed pressure (mmHg) as recently described [ 1 I.
Extracorporeal coronary perfusion
The left anterior descending coronary artery (LAD) was isolated distal to the first major branch, cannulated, and extracorporeally perfused from a pressurised reservoir. Blood for normoxaemic perfusion was withdrawn from the right femoral artery. For hypoxaemic perfusion, blood was withdrawn from the right femoral vein and equilibrated with O,, CO, and N, in a Spiraflo infant blood oxygenator to produce blood with decreased 0, and normal CO, contents. Coronary hypoperfusion was produced by reducing the pressure of the perfusion reservoir sufficient to lower LAD perfusion pressure to 60 mmHg. LAD perfusion pressure was monitored with a saline-filled PE-50 catheter advanced to the orifice of the LAD cannula and connected to a Statham P23XL pressure transducer. LAD blood flow was measured with an in-line electromagnetic flow probe. The anterior interventricular vein was cannulated with PE-50 tubing and allowed to drain freely into a beaker. Coronary arterial and venous samples were collected and PO,, PCO,, pH, oxygen content, and lactate concentration were measured as recently described [l] . Myocardial 0, consumption (MVO,; ml . min-' . g tissue-') and percent extraction of 0, and lactate were computed as previously detailed [ 11. Oxygen utilisation efficiency was taken as the ratio of regional myocardial power divided by MVO,.
At the conclusion of the protocols, the LAD perfusion territory was delineated with india ink, excised and weighed. 0, consumption and coronary flow were normalised per g tissue mass.
Experimental protocols
Following a 60 min post-surgical stabilisation period, each heart was subjected to one of the protocols illustrated in Fig. 1 . Five groups of experiments were performed. In group 1, regional myocardial responses to isoprenaline infusions were measured before and during intracoronary adenosine infusion. In groups 2A and 2B, the effects of intracoronary adenosine deaminase (ADA) and erythro-9-(2-hydroxy-3-nonyl)-adenine . HCl (EHNA), respectively, on the myocardial response to isoprenaline during reductions in coronary perfusion pressure were studied. In groups 3A and 3B, the effects of these interventions were studied during coronary hypoxaemia. Haemodynamic variables, dP/dr, segment lengths, and coronary arterial and venous blood gases and lactate were measured at the indicated time points. Fig. 1 indicates the designations for data collected at each of these times and reported in the figures and tables. Isoprenaline was infused at 0.025 pg . min-' . kg-'; this rate was sufficient to appreciably increase regional function but did not significantly alter heart rate or 0, utilisation efficiency under baseline conditions [ 11. Isoprenaline infusions were limited to 90 s to avoid systemic haemodynamic effects due to prolonged isoprenaline infusion. In group 1, adenosine was infused into the LAD at a rate of 40 pg . min-'.
Adenosine deaminase was infused into the LAD at a rate of 5 unit . min-' . kg-'. ADA (type VIII, Sigma, St. Louis, MO, USA) was diluted in 0.2 mM sodium phosphate buffer, pH 7.4, to a concentration of 100 U. ml-' and filtered (0.45 pm pore) before infusion. In preliminary experiments, ADA blunted the hyperaemic response to a 50 pg i.c. adenosine bolus: before ADA, coronary flow increased 96 + 6%; during ADA infusion, flow increased only 35 * 4% (P < 0.05).
To inhibit native myocardial adenosine deaminase activity, EHNA was infused into the LAD at 0.25 nmol + min-' . kg-'. It has been demonstrated [13] that intracoronary EHNA infusion at this rate is sufficient to completely block ischaemic catabolism of myocardial adenylates in in situ canine heart. EHNA was dissolved in 0.15 M NaCl to a concentration of 1.24 . lo-' M and filtered (0.45 pm pore) prior to infusion.
Statisrical analysis
All data are expressed as means (s.e.m.1. Multiple comparisons of means within each group were accomplished by analysis of variance for repeated measures in combination with least significant difference pairwise comparisons. Statistical significance was accepted at P < 0.05. In the tables and figures, significant differences are denoted by symbols ( )* , ', '). Data sharing the same symbol are not significantly different. On the other hand, data marked differently are significantly different.
Results

Effects of intracoronary
adenosine on isoprenalinestimulated myocardium at normal coronary perfusion pressure
In group 1, the effects of intracoronary adenosine infusion on regional function and 0, utilisation efficiency were studied. Prior to adenosine infusion, intracoronary isoprenaline increased coronary flow and d P/dt by 70 and 56%, respectively, but did not alter heart rate or left ventricular developed pressure (Table 1) . Importantly, lactate extraction was not decreased by isoprenaline. Adenosine produced a fourfold increase in coronary flow which was further increased by simultaneous isoprenaline infusion; however, adenosine did not alter global cardiac function and lactate extraction in either the absence or presence of isoprenaline.
The effects of isoprenaline and adenosine on regional myocardial function, 0, consumption, and 0, utilisation efficiency are presented in Fig. 2 . Isoprenaline nearly doubled systolic segment shortening and regional power ( Fig. 2A, 2B) ; th ese responses were not affected by adenosine. Isoprenaline also nearly doubled MVO, (Fig. 2C) , with the result that 0, utilisation efficiency was unaffected (Fig. 2D ). Interestingly, adenosine significantly attenuated MVO, during isoprenaline stimulation. Because regional power was not affected by adenosine, 0, utilisation efficiency during isoprenaline stimulation was significantly increased by adenosine (Fig. 2D ).
3.2. Efsects of adenosine deaminase and EHNA at normal coronary 0, supply During normoxaemic coronary perfusion at 100 mmHg perfusion pressure, ADA attenuated isoprenaline-induced coronary vasodilation and isoprenaline enhancement of d P/dt (P < 0.05; Table 2 ). The enzyme also markedly attenuated the increases in segment shortening and regional power during isoprenaline stimulation (P < 0.05; Fig. 3A, 3B ). Under the influence of ADA, MVO, during isoprenaline stimulation fell in proportion to the decrease in regional function (Fig. 3C) . Consequently, regional 0, utilisation efficiency was essentially unaltered by ADA when coronary 0, supply was not experimentally limited ( Fig. 3D ). Percent lactate and oxygen extractions also were unaffected by ADA in both the absence and presence of isoprenaline (Table 2) ; thus, the decrement in contractile function during ADA treatment was not due to ischaemia.
Erythro-9-(2-hydroxy-3-nonyl)-adenine . HCl did not alter coronary flow, global cardiac function, and regional lactate extraction in the unstimulated heart, and did not alter the response to isoprenaline. Although EHNA did not appreciably affect regional performance (Fig. 4A, B) or MVO, (Fig. 4C) , it did modestly enhance 0, utilisation efficiency under these baseline perfusion conditions (Fig.  4D) . Thus, when degradation of endogenous adenosine was inhibited, or exogenous adenosine was infused, regional cardiac efficiency was increased when coronary 0, supply was normal. These experiments provided an early indication that adenosine could mediate down-regulation of myocardial 0, demand. Subsequent studies tested the possibility that adenosine mediates the marked myocardial Table I The responses to adenosine infusion (ADO) and to isoprenaline ( AoP, mean aortic pressure; HR. heart rate; PP. coronary perfusion pressure; LVP, left ventricular developed pressure ( = peak systolic pressureend diastolic pressure); dP /dr, maximum rate of increase of LVP; CaO,, coronary arterial oxygen content; CvO,, coronary venous oxygen content; PvO,, coronary venous oxygen tension; CBF, blood flow in left anterior descending coronary artery; La%, coronary lactate extraction; O,%, coronary oxygen extraction.
* .'.+ Different from other values in same column at P < 0.05. Table 2 The responses to adenosine deaminase infusion (ADA) and to IS0 infusions in the absence (ISO) and presence (ADA + ISO) of ADA Conditions AoP (mmHg) HR (mini '> PP (mmHg) Values are means (s.e.m.), n = 7. Abbreviations as in Table I .
' .' Different from other values in same column at P < 0.05.
R.T. Mullet et ul./Cardiovoscular
Reseurch 31 (1996) Table 3 The responses to ADA infusion and to IS0 infusions in the absence and presence of ADA at low coronary perfusion pressure (LP) Conditions Table I . Table 4 The responses to EHNA infusion and to IS0 infusions in the absence and presence of EHNA at tow coronary perfusion pressure Conditions Values are means (s.e.m.), n = 6. Abbreviations as in Table I .
' .' Different from other values in same column at P < 0.05. 16 down-regulation that occurs during adrenergic stimulation of myocardium at reduced coronary 0, supply.
R.T. Mullet et al./ Curdiovuscuhr
3.3. Effects of adenosine deaminase and EHNA at decreased coronary perfusion pressure
To examine the role of endogenous adenosine in modulating myocardial 0, demand during limitations in coronary 0, supply, endogenous adenosine concentrations were altered with two interventions: ADA was infused into the LAD to degrade endogenous adenosine, or the ADA inhibitor EHNA was infused to block adenosine degradation. When coronary perfusion pressure was decreased from 100 to 60 mmHg, ADA slightly attenuated isoprenaline enhancement of d P/d t (P < 0.05; Table 3 ). The enzyme did not curtail coronary vasodilation due to isoprenaline, in contrast to the response at 100 mmHg perfusion pressure (Table 2) . ADA blunted isoprenaline enhancements of systolic shortening and regional power (Fig. 5A, B) , but did not lessen the increase in MVO, (Fig. 5C) . As a consequence, ADA nearly eliminated the enhancement of regional myocardial 0, utilisation efficiency (Fig. 5D ) that occurred during isoprenaline infusion at decreased coronary perfusion pressure.
When endogenous ADA was inhibited by EHNA, the results were opposite to those of ADA infusion. Thus, A 40 1 EHNA increased (P < 0.05) the d P/d t response to isoprenaline at reduced coronary perfusion pressure (Table 4) . EHNA also augmented systolic segment shortening and regional power during isoprenaline infusion, while MVO, was unchanged (Fig. 6) . EHNA also enhanced myocardial 0, utilisation efficiency. Thus, myocardial 0, utilisation efficiency of isoprenaline-stimulated, moderately hypoperfused myocardium was markedly influenced by interventions that modified endogenous adenosine levels: efficiency fell when endogenous adenosine was degraded by ADA, and rose when adenosine degradation was inhibited with EHNA.
Effects of adenosine deaminase and EHNA during coronary hypoxaemia
The response of hypoxaemic myocardium to isoprenaline stimulation (decreased cardiac power) differs from the response during hypoperfusion (increased 0, utilisation efficiency), although both responses lessen myocardial 0, demand [l] . Studies in hypoxaemic myocardium were performed to determine whether adenosine mediates the reduction in power. Table 5 presents global haemodynamic variables and coronary resistance in ADA-treated hearts before and during regional hypoxaemic perfusion. The decline in isoprenaline enhancement of dP/dt seen in Fig. 6 . Regional contractile and metabolic responses to isoprenaline infusion in the absence and presence of intracoronary EHNA during moderate coronary hypoperfusion (LP). Means + s.e.m. from 6 experiments from the group 2 protocol. * P < 0.05 VS. other values; ' P < 0.05 vs. LP + ISO. Table 5 The responses to hypoxaemia (HX) and to IS0 infusions during normoxaemia Values are means (s.e.m.), )I = 7. Abbreviations as in Table I .
' "" Different from other values in same column at P < 0.05. Table 6 The responses to hypoxaemia and to IS0 infusions during normoxaemia In contrast to untreated hearts 111, hypoxaemia did not attenuate the enhancement of systolic segment shortening during isoprenaline infusion in the ADA-treated myocardium (Fig. 7A) , although regional power did fall (P < 0.05; Fig. 7B ). 0, demand was also unaffected by hypoxaemia in these hearts (Fig. 7C) . Hypoxaemia tended to decrease 0, utilisation efficiency during isoprenaline stimulation (Fig. 7D ), but this effect was not significant. Thus, degradation of endogenous adenosine prevented the fall in 0, demand but did not lessen 0, utilisation efficiency in hypoxaemic myocardium during isoprenaline stimulation.
In EHNA-treated myocardium, hypoxaemia intensified the isoprenaline enhancement of d P/dt (Table 6 ). EHNA did not affect coronary resistance under baseline or hypoxic conditions, in both the absence and presence of isoprenaline. In EHNA-treated hearts, hypoxaemia did not attenuate isoprenaline enhancement of segment shortening (Fig. 8A ) and regional power (Fig. 8B ), but sharply lowered MVO, (Fig. 8C) . Consequently, 0, utilisation efficiency during /3-adrenergic stimulation in EHNA-treated myocardium rose significantly during hypoxaemia (Fig.  SD) . Thus, when degradation of endogenous adenosine was inhibited during isoprenaline stimulation of hypoxaemic myocardium, 0, utilisation efficiency was increased, in contrast to the response observed when endogenous adenosine deaminase remained active or when the enzyme was infused into the hypoxaemic segment.
Discussion
We have previously demonstrated that isoprenalinestimulated, in situ canine myocardium down-regulates its oxygen demand and thereby avoids ischaemia when subjected to moderate reductions in coronary oxygen supply [l] . The specific response producing a reduction in 0, demand appeared to differ in hypoxaemic vs. hypoperfused myocardium: hypoperfused myocardium increased its 0, utilisation efficiency, while hypoxaemic myocardium lowered its power and thus energy expenditure. The present study was undertaken to delineate the mechanisms for decreased myocardial 0, demand during hypoperfusion and hypoxaemia. Specifically, we tested the hypothesis that adenosine mediates the apparently disparate responses under these two conditions. The principal findings are summarised as follows. In normally perfused and oxygenated myocardium, exogenous adenosine reduced MVO, with no decrement in power and, thus, increased 0, utilisation efficiency during P-adrenergic stimulation with isoprenaline. When 0, supply was restricted by lowering coronary perfusion pressure, exogenous adenosine deaminase attenuated the isoprenaline-induced elevation in regional power and MVO,; 0, utilisation efficiency was not enhanced. Inhibition of endogenous adenosine deaminase with EHNA had the opposite effect: regional power and 0, utilisation efficiency were increased. When 0, supply was limited by moderate hypoxaemia, adenosine deaminase lessened isoprenaline stimulation of regional power but not 0, consumption and, thus, decreased regional myocardial 0, utilisation efficiency. On the other hand, EHNA attenuated the increase in MVO, but not the increase in power during isoprenaline stimulation and enhanced 0, utilisation efficiency. Thus, endogenous adenosine appeared to play a significant role in increasing 0, utilisation efficiency when 0, supply was impeded, particularly during moderate hypoperfusion.
To test the possibility that endogenous adenosine mediated increases in 0, utilisation efficiency, myocardium was treated with intracoronary infusions of adenosine deaminase. It was essential to produce interstitial ADA activities sufficient to degrade endogenous adenosine formed during isoprenaline stimulation. In the present study, ADA was infused into the LAD at a rate of 5 units . min-' . kg-'. Saito and coworkers [21] found that 5-10 min ADA infusion at this rate increased mean interstitial ADA activity to 6 units. ml-' at 38°C. At an adenosine concentration of 100 nM, one unit. ml-' of ADA deaminates the nucleoside at a rate of 4.8 . 10e9 mol. min-' . ml-' [22] . At an adenosine production rate of 3-6 . lo-' mol. min-' kg-' in ischaemic myocardium [23] , an ADA activity of 6 units. ml-' will maintain interstitial adenosine concentration at 0.1-0.2 FM, i.e. at the levels reported in normoxic working myocardium [4, [15] [16] [17] 241 . It was thus assumed that an ADA infusion of 5 units . min-' . kg-' would prevent an increase in interstitial adenosine concentration during isoprenaline stimulation. 4 .1. EfSect of isoprenaline on interstitial adenosine when coronary 0, supply is reduced During metabolic stress, myocardial adenosine formation from adenine nucleotide precursors is accelerated. The rate of myocardial adenosine release could also be increased when coronary perfusion pressure is moderately decreased [ 141. Therefore, it is likely that interstitial adenosine concentration was increased under the conditions where 0, demand was decreased and coronary 0, supply simultaneously limited except, of course, during treatment with ADA. Rigorous testing of this assertion would require measurements of interstitial adenosine. Unfortunately, direct measurements of interstitial adenosine concentration cannot be obtained with currently available techniques. Moreover, indirect techniques for estimating interstitial adenosine, including sampling of epicardial transudate [5, 9, , epicardial diffusion wells and discs [18, 19] , and microdialysis [20] lack the temporal resolution necessary to monitor changes in interstitial adenosine levels during 90 s infusions of isoprenaline as done in this study. However, the following evidence suggests that the effect of isoprenaline to increase interstitial adenosine concentration was magnified by reductions in coronary arterial 0, supply. At baseline coronary perfusion pressure (100 mmHg), adenosine deaminase did not appreciably affect myocardial 0, utilisation efficiency during isoprenaline stimulation (Fig. 3D) , but when coronary perfusion pressure was lowered to 60 mmHg (Fig. 5D) , adenosine deaminase decreased efficiency by 35% (P < 0.05). The ability of EHNA to increase myocardial efficiency during isoprenaline stimulation was also markedly intensified by coronary hypoperfusion (Fig. 4D, 6D) . Thus, the effects of interventions that altered interstitial adenosine were accentuated by reductions in coronary perfusion pressure.
During coronary hypoxaemia, on the other hand, adenosine deaminase did not significantly lower efficiency during isoprenaline infusion (Fig. 7D) , and the EHNA-induced increase in efficiency (Fig. SD) was attenuated relative to EHNA's effects during hypoperfusion (Fig.  6D) . Thus, interstitial adenosine did not appear to increase during hypoxaemia to the same extent as during hypoperfusion. This finding is consistent with the recent report of Van wylen and coworkers [25] , where regional hypoxaemia more severe than that of the present study only transiently and modestly increased interstitial fluid adenosine concentration as estimated by microdialysis.
Mechanisms for enhancement of myocardial 0, utilisah'on ejficiency
Adenosine exerts an array of protective effects in myocardium [26] . Schrader et al. [7] and Dobson and Fenton [5, 8, 9] proposed that adenosine could help correct an imbalance between 0, supply and demand in the myocardium during sympathetic stimulation by reducing myocardial contractile responses to adrenergic stimulation and, thus, myocardial 0, demand. In contrast to these previous studies, adenosine did not lower myocardial 0, demand by attenuating isoprenaline-stimulated d P/d t or systolic segment shortening; instead, adenosine lowered 0, demand by increasing 0, utilisation efficiency, with no decrement in function. In hypoperfused myocardium, augmentation of interstitial adenosine with EHNA increased regional power but not 0, demand as reflected by MVO,; in hypoxaemic myocardium, EHNA lowered 0, demand but not power. In both cases, 0, utilisation efficiency was enhanced without a reduction in the contractile response to isoprenaline. When ADA was infused to degrade interstitial adenosine, regional power was lowered and 0, utilisation efficiency was attenuated in hypoperfused, isoprenalinestimulated myocardium. Thus, the effects of adenosine during the present moderate limitations in coronary 0, supply appear to diverge from the antiadrenergic effects reported previously.
The specific cellular mechanisms for adenosine-mediated enhancement of 0, utilisation efficiency are unknown. Adenosine has been shown to shift myocardial energy expenditure from that related to heart rate to that necessary for pressure development or volume ejection [27] . In the present study adenosine, isoprenaline, adenosine deaminase and EHNA were infused only into the anterior left ventricular free wall and likely did not influence sinoatrial nodal function or myocytic depolarization in other regions of the myocardium. Consequently, heart rate was relatively constant throughout the protocols. Thus, increased myocardial 0, utilisation efficiency was probably not due to negative chronotropic effects of adenosine.
Another possible mechanism for adenosine-enhanced efficiency could involve a shift in substrate oxidation from lipid to carbohydrate. Fatty acids require 12% more 0, than carbohydrates to generate the same amount of ATP. In accordance with this oxygen-sparing effect of carbohydrate substrates relative to lipid, inhibition of lipolysis nearly abolished myocardial fatty acid uptake and reduced MVO, [28] . Conversely, isoprenaline stimulation mobilizes fatty acids and increases MVO, disproportionate to the increase in work [29, 30] . When adenosine was infused into isolated rat hearts metabolising glucose and palmitate, glucose oxidation was increased relative to palmitate oxidation and efficiency was also enhanced. Kahles et al. [31] demonstrated that the adenosine analogue N6-alkyl-N6-cyclohexyl-adenosine promoted myocardial glucose uptake during coronary occlusions. If endogenous adenosine produces similar shifts in substrate oxidation in hypoperfused, in situ canine myocardium, this could account for at least part of the observed enhancement of oxygen utilisation efficiency during isoprenaline stimulation.
At coronary perfusion pressures within the autoregulatory range, subendocardial flow is essentially equal to subepicardial flow in canine myocardium. In a previous study, when perfusion pressure was lowered to 60 mmHg, as in the present moderate coronary hypoperfusion, subepicardial flow remained constant while subendocardial flow fell 20% [32] . Hypoxaemia, on the other hand, produces a generalised vasodilation and no transmural flow redistribution [33] . Thus, transmural flow redistribution must be considered in evaluating the different responses of regional power and 0, utilisation efficiency to isoprenaline during hypoxaemia vs hypoperfusion. When coronary perfusion pressure was lowered from 100 to 60 mmHg, myocardial 0, consumption fell 30% in the absence and 40% in the presence of isoprenaline. If this reduction in 0, demand were due to hypoperfusion in the subendocardial third of the anterior wall, rather than a transmural increase in 0, utilisation efficiency, subendocardial 0, consumption would have had to virtually cease to produce decreases in transmural oxygen consumption of these magnitudes, and severe subendocardial ischaemia would have been present. Such subendocardial ischaemia would have converted lactate extraction in the subendocardium to net lactate release. There would have been a clearly evident decrease in transmural lactate extraction. Since transmural lactate extraction was unchanged during reductions in coronary perfusion pressure and was not attenuated by isoprenaline either before or during hypopet-fusion in this study, it would appear that any decrease in subendocardial perfusion was accompanied by down-regulation of myocardial oxygen demand rather than producing myocardial ischaemia.
The disparity between responses to isoprenaline during hypoxaemia vs hypoperfusion could have arisen from increased collateral flow when coronary perfusion pressure was lowered to 60 mmHg. This would have resulted in an underestimation of myocardial blood flow and calculated 0, consumption in the hypoperfused territory. However, Vinten-Johansen et al. [34] reported that collateral flow from normally perfused in situ canine myocardium did not significantly increase when left anterior descending perfusion pressure was reduced to 50 mmHg. In the present study, left anterior descending perfusion pressure was only lowered to 60 mmHg; thus, it is unlikely that collateral flow increased sufficiently during mild hypoperfusion to have produced a significant underestimation of regional myocardial oxygen consumption. 4.3 . Is the present down-regulation myocardial 'hibernation ' ?
The down-regulation of oxygen demand produced by moderate reductions in coronary oxygen supply is clearly distinct from the recently characterized phenomenon of myocardial 'hibernation'.
Hibernation is a reversible down-regulation of myocardial energy demand that appears to preserve energy metabolites and protect the myocardium during ischaemia [35, 36] . Since 0, extraction reserves are limited in hibernating myocardium, inotropic stimulation with norepinephrine [37] or pacing [36] does not appreciably increase MVO, and results in degradation of myocardial high energy phosphate reserves. In the present study, MVO, increased in response to isoprenaline, indicating that oxygen extraction reserves were still available to the hypoperfused or hypoxaemic myocardium. Myocardial lactate extraction was not attenuated, nor did contractile function decline, following induction of moderate hypoperfusion or hypoxaemia. Thus, ischaemia was not evident in the present experiments. Although the present down-regulation is not ischaemic myocardial hibernation, it is still possible that the two phenomena are mediated by similar mechanisms.
In summary, degradation of interstitial adenosine attenuates 0, utilisation efficiency in isoprenaline-stimulated hypoxaemic or hypoperfused canine myocardium, while efficiency is enhanced by inhibiting adenosine degradation. These findings are taken as evidence that interstitial adenosine mediates an increase in efficiency and thus reduces myocardial 0, demand when coronary 0, supply is moderately decreased, a response which could enable the myocardium to avoid ischaemia. It remains to be determined whether the observed enhancement of efficiency is specific to isoprenaline or is a general response to other interventions that stimulate myocardial oxygen demand, e.g. sympathetic nerve stimulation, pacing-induced tachycardia, or hypercalcaemia. Also, the intriguing possibility that changes in 0, utilisation efficiency occur in human myocardium has not been tested.
